Research Article
Characterization of the Antibiotic Compound No. 70 Produced by Streptomyces sp. IMV-70
Table 1
(a) Antimicrobial activity of antibiotic no. 70. (b) Antimicrobial activity of antibiotic no. 70 against clinical microorganisms.
(a) |
| Test organisms | Minimum inhibitory | concentration, μg/mL |
| Comamonas terrigena ATCC 8461 | 0.1 | Bacillus subtilis ATCC 6633 | 0.25 | Staphylococcus aureus FDA 209 P | 0.05 |
|
|
(b) |
| Microorganisms | Inhibition zone size (mm) |
| S. haemolyticus NMR 713 | 24 | S. haemolyticus NMR 1626 | 22 | S. haemolyticus NMR 1642 | 22 | S. haemolyticus NMR 1742 | 24 | S. epidermidis NMR 1656 | 22 | S. epidermidis NMR 1694 | 21 | S. epidermidis NMR 351 | 23 | S. epidermidis NMR 793 | 22 | S. epidermidis NMR 813 | 23 | S. haemolyticus NMR 781 | 20 | S. lugdunensis NMR 348 | 24 | Str. agalactiae NMR 303 | 22 | Str. agalactiae NMR 685 | 22 | Str. agalactiae NMR 782 | 22 | Str. agalactiae NMR 1002 | 25 | Str. oralis NMR 1565 | 26 | Str. pneumoniae NMR 1150 | 24 | Enterococcus hirae NMR 459 | 19 | Enterococcus faecalis NMR 425 | 16 | Enterococcus faecalis NMR 118 | 16 | Enterococcus faecalis NMR 670 | 17 | Enterococcus faecalis NMR 733 | 16 |
|
|